Status:
COMPLETED
Telerehabilitation for Post COVID-19 Condition
Lead Sponsor:
Université de Sherbrooke
Collaborating Sponsors:
Hotel Dieu Hospital
Conditions:
Long COVID
Chronic Fatigue Syndrome
Eligibility:
All Genders
25-65 years
Phase:
NA
Brief Summary
Telerehabilitation is a great alternative to offering care during a global pandemic. 85% of patients with COVID-19 report persistent symptoms up to 8 months after the infection. There are no clear rec...
Detailed Description
Telerehabilitation is a great alternative to offering care during a global pandemic. 85% of patients with COVID-19 report persistent symptoms up to 8 months after the infection. There are no clear rec...
Eligibility Criteria
Inclusion
- Living in the community
- Living near Sherbrooke (\<50km)
- Having a diagnostic of COVID-19 confirmed (PCR) and post-COVID syndrome (according to the World Health Organization criteria)
- Being aged between 25 and 65 years old
- Having access to internet at home
- Living with a family member/caregiver or having a telephone or a medical alert system (in case of emergency)
- Reporting persistent fatigue symptoms according to the Fatigue Severity Scale (FSS) (score≥4/7)
- Reporting functional limitations according to the Post-COVID-19 Functional Status scale (PCFS (score ≥2/4);
- Being able to give free and informed consent (adequate understanding of the study protocol);
- Agreeing to perform a pulmonary function test, an exercise stress test, and an ergospirometric exercise test (adequate understanding of steps and procedures);
- Having a low exercise capacity and moderate-to-severe cardiovascular risk \<7 metabolic equivalent of a task (MET) or ≤9 if significant reduction of self-reported exercise tolerance according to the stress test performed on a treadmill - Cornell protocol);
- Having no other potential explanatory causes for fatigue or reduced exercise capacity according to medical evaluation
Exclusion
- Cognitive impairment: Mini-Mental State Examination (MMSE) ≤24/30
- Inability to perform or understand study procedures
- Medical contraindication
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 8 2022
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT05973136
Start Date
April 1 2022
End Date
August 8 2022
Last Update
August 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Université de Sherbrooke
Sherbrooke, Quebec, Canada, J1H 5N4